Lung Cancer Edition: Top Headlines for Week of October 14, 2024
- Author
- Healio
- Published
- Thu 17 Oct 2024
- Episode Link
- http://sites.libsyn.com/408806/lung-cancer-edition-top-headlines-for-week-of-october-14-2024
In this edition, FDA approves Rybrevant for advanced lung cancer, screening orders in eligible patients higher with digital health program and more. Read the full coverage here:
FDA approves Rybrevant for advanced lung cancer
Lung cancer screening orders in eligible patients higher with digital health program
FDA approves Opdivo regimen for resectable NSCLC
Study quantifies survival benefit of immunotherapy in metastatic NSCLC
FDA expands osimertinib approval for advanced non-small cell lung cancer
References:
